Glycoprotein News and Research

RSS
New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Study explores the role of dynamin protein DYN-1 in regenerative axonal fusion

Study explores the role of dynamin protein DYN-1 in regenerative axonal fusion

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Study findings could be harnessed to engineer new botulinum neurotoxin E variants

Study findings could be harnessed to engineer new botulinum neurotoxin E variants

Vein-on-a-chip model can help understand the mechanisms of blood clot formation

Vein-on-a-chip model can help understand the mechanisms of blood clot formation

Research identifies Th1 memory CD4+ T cells as key to protect against emerging poxvirus skin infections

Research identifies Th1 memory CD4+ T cells as key to protect against emerging poxvirus skin infections

Print your own vaccine: automatic printing of microneedle patch COVID-19 mRNA vaccines

Print your own vaccine: automatic printing of microneedle patch COVID-19 mRNA vaccines

Revolutionizing Glycobiology: A Mass Spectrometrist's Perspective

Revolutionizing Glycobiology: A Mass Spectrometrist's Perspective

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study highlights the potential long-term neurological effects post-COVID-19

Study highlights the potential long-term neurological effects post-COVID-19

Study reveals SARS-CoV-2 on hands and frequently-touched surfaces as key predictors of household transmission

Study reveals SARS-CoV-2 on hands and frequently-touched surfaces as key predictors of household transmission

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Epigenome reprogramming after SARS-CoV-2 infection

Epigenome reprogramming after SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.